GlassScriptPhysician profile
Amy Marie Murphy
NPI 1821430281
$2,406.33
in general payments reported to CMS, 2019-2025
29 companies · $72.64 in 2025
The $72.64 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $747 · 2022: $609 · 2023: $527 · 2024: $451 · 2025: $72.64.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,050.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,050.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $610.84 | 2021-2024 | |
| Mayne Pharma Commercial LLC | $398.45 | 2021-2025 | |
| Exeltis, USA INC. | $156.41 | 2021-2024 | Slynd |
| Therapeuticsmd, INC. | $149.17 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $141.48 | 2021-2024 | |
| Astellas Pharma US INC | $125.60 | 2023-2024 | Veozah |
| Organon LLC | $90.37 | 2021-2024 | Nexplanon |
| Merck Sharp & Dohme LLC | $72.10 | 2021-2023 | Gardasil 9 |
| Pfizer INC. | $71.87 | 2022-2025 | |
| Coopersurgical, INC. | $68.61 | 2021-2024 | Paragard T 380a |
| Medicem INC. | $53.21 | 2021-2023 | |
| Agile Therapeutics, INC. | $46.95 | 2021-2023 | Twirla |
| Myovant Sciences INC. | $41.02 | 2021-2022 | |
| Shield Therapeutics INC | $38.63 | 2024 | |
| Optumhealth Care Solutions, LLC | $34.02 | 2024 | Eitan Medical, Vivify Health Care Team Portal 001 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $32.91 | 2022 | |
| Sumitomo Pharma America, INC. | $30.60 | 2023-2024 | Myfembree |
| Avion Pharmaceuticals | $28.65 | 2021-2023 | Balcoltra |
| Axonics, INC. | $24.26 | 2023 | Axonics, Bulkamid |
| Glaxosmithkline, LLC. | $23.32 | 2021 | |
| Hologic Sales and Service, LLC | $23.26 | 2025 | Aptima |
| Mycovia Pharmaceuticals, INC. | $23.23 | 2023 | Vivjoa |
| Coloplast Corp | $22.84 | 2024 | |
| Gynesonics, INC. | $20.88 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Aspira Women'S Health INC | $18.22 | 2024 | Ova1 |
| C. R. Bard, INC. & Subsidiaries | $16.72 | 2023 | Bd Onclarity |
| Mylan Pharmaceuticals INC. | $16.18 | 2021 | |
| Sage Therapeutics, LLC | $13.77 | 2025 | Zurzuvae |
| Exact Sciences Corporation | $12.76 | 2023 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Murphy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.